Reversal of MRP-Mediated Multidrug Resistance in Human Lung Cancer Cells by the Antiprogestatin Drug RU486

By Payen L.   delugin L.   Courtois A.   Trinquart Y.   Guillouzo A.   Fardel O.  

Biochemical and Biophysical Research Communications, Vol. 258, Iss. 3, 1999-05 ,pp. : 513-518

Elsevier

Access to resources Recommend Favorite

A Leukotriene Receptor Antagonist, ONO-1078, Modulates Drug Sensitivity and Leukotriene C₄Efflux in Lung Cancer Cells Expressing Multidrug Resistance Protein

By Nakano R.   Oka M.   Nakamura T.   Fukuda M.   Kawabata S.   Terashi K.   Tsukamoto K.   Noguchi Y.   Soda H.   Kohno S.  

Biochemical and Biophysical Research Communications, Vol. 251, Iss. 1, 1998-10 ,pp. : 307-312

Elsevier

Access to resources Recommend Favorite

Chromosome microdissection identifies genomic amplifications associated with drug resistance in a leukemia cell line: an approach to understanding drug resistance in cancer

By Mahjoubi Frouzandeh   Hill Ronald   Peters Greg  

Chromosome Research, Vol. 14, Iss. 3, 2006-04 ,pp. : 263-276

Springer Publishing Company

Access to resources Recommend Favorite

Studies on the Relationship between Estrogen Receptor Content, Glutathione S-Transferase pi Expression, and Induction by 2,3,7,8-Tetrachlorodibenzo-p-dioxin and Drug Resistance in Human Breast Cancer Cells

By Hoivik D.   Wilson C.   Wang W.   Willett K.   Barhoumi R.   Burghardt R.   Safe S.  

Archives of Biochemistry and Biophysics, Vol. 348, Iss. 1, 1997-12 ,pp. : 174-182

Elsevier

Access to resources Recommend Favorite

Genetically modified dendritic cells – a new, promising cancer treatment strategy?

By Wysocki PJ   Grabarczyk P   Mackiewicz-Wysocka M   Kowalczyk DW   Mackiewicz A  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 8, 2002-12 ,pp. : 835-845

Informa Healthcare

Access to resources Recommend Favorite